Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2017-10-04
2018-02-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Protein Consumption in Critically Ill Patients
NCT03048487
Protein Dosing Strategies in Critically Ill Patients: Comparing Actual Body Weight and Fat-Free Mass Approaches in an Observational Cohort Study
NCT07312708
Supplemental Enteral Protein in Critical Illness
NCT03170401
PRotEin Provision in Critical IllneSs
NCT04633421
Replacing Protein Via Enteral Nutrition in Critically Ill Patients
NCT04475666
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-very high protein enteral nutrition
20 enterally fed critically ill adult patients prior to the introduction of a very high protein enteral nutrition formula \[2015\].
No interventions assigned to this group
Post-very high protein enteral nutrition
20 enterally fed critically ill adult patients post the introduction of a very high protein enteral nutrition formula \[2016\].
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Received enteral nutrition for a minimum of five days during the first week of ICU admission
Exclusion Criteria
* Acute renal failure not dialyzed
* Hepatic encephalopathy grade 3 or 4
* Intentional underfeeding/trophic feeding - including refeeding syndrome
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hamilton Health Sciences Corporation
OTHER
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michele ApSimon
Role: PRINCIPAL_INVESTIGATOR
Hamilton Health Sciences Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hamilton Health Sciences
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16.02.CA.HCN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.